ELEV - Elevation Oncology, ...

Chart of Elevation Oncology, Inc.(ELEV), Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeu

Elevation Oncology, Inc.

ELEV

NASDAQ

Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is based in New York, New York.

4.43 USD

-0.3 (-6.77%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

Historical Prices

From:

To:

We are unable to load the chart at this time.

FMP

Home Terms of Service Privacy Policy Blog Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.